Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Stay vigilant for fake initial coin offerings by examining whitepapers, token metrics, and regulatory disclosures to prevent losses.
17,900 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Bitcoin sits in the mid-60,000s after retreating from late-2025 highs, while on-chain activity slows and whale accumu...
Windfalls from settlements and inheritances are surging in 2026, but experts warn these gains often fade within a few...
GhostSwap launches a no-onboarding swap experience that lets users exchange 1,600+ tokens in minutes, without email, ...
The 2026 software stock sell-off has traders buzzing, even as many companies post solid results. Is AI disruption fea...
Coca-Cola and Philip Morris International both beat expectations in Q1 2026 and now sit near 52-week highs. Analysts ...
Greg Abel, seen as Warren Buffett's successor, made a bold move by trimming UnitedHealth from Berkshire's portfolio. ...
Snap enters 2026 with a volatile but potentially rewarding path. Analysts weigh user growth, ad monetization, and new...
Steve Wozniak reflects on the motivations behind founding Apple, revealing a desire for invention over cash and a $50...
Tesla faces a valuation crossroads as AI-driven growth challenges traditional EV metrics. The stock trades near $412 ...
Two dividend stocks double right now can help steady your income while you grow wealth. We break down two dependable ...
Three leading space names moved higher in a risk-on trading session, with AST SpaceMobile, Rocket Lab and Planet Labs...